We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CSBTF market cap is 1.02B. The company's latest EPS is CHF -0.3726 and P/E is -74.34.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 2.56M | 4.04M | 13.82M | 17.99M | 33.56M |
Operating Income | -11.39M | -11.68M | -8.77M | -13.45M | -13.19M |
Net Income | -11.25M | -11.52M | -7.54M | -14.6M | -13.73M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 87.85M | 94.36M | 91.34M | 82.95M | 71.46M |
Total Liabilities | 10M | 9.76M | 14.36M | 14.09M | 14.75M |
Total Equity | 77.86M | 84.6M | 76.98M | 68.86M | 56.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -10.85M | -9.24M | -5.45M | -7.35M | -8.84M |
Investing | -118k | -220k | -374k | -400k | -326k |
Financing | 13.13M | 17.08M | 6.08M | 3.22M | -171k |
Market Cap | 1.02B |
Price to Earnings Ratio | -74.34 |
Price to Sales Ratio | 30.4 |
Price to Cash Ratio | 71.82 |
Price to Book Ratio | 17.99 |
Dividend Yield | - |
Shares Outstanding | 36.84M |
Average Volume (1 week) | 200 |
Average Volume (1 Month) | 2.87k |
52 Week Change | 483.16% |
52 Week High | 36.10 |
52 Week Low | 3.8505 |
Spread (Intraday) | 6.48 (23.07%) |
Company Name | Kuros Bioscience Ltd (PK) |
Address |
wagistrasse 25 zurich 8952 |
Website | https://www.kurosbio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions